Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 23376085 | HLA-DRB1*01 | chagas disease | NA | NA | NA | unclassified | |
| 21-hydroxylase gene mutant allele cyp21a2*15 strongly linked to the resistant hla haplotype b*14:02-drb1*01:02 in chronic chagas disease. | |||||||
| 23376085 | HLA-B*14 | chagas disease | NA | NA | NA | unclassified | |
| we previously reported protective haplotype hla-b*14:02-drb1*01:02 against chronic chagas disease in bolivia. | |||||||
| 23376085 | HLA-DRB1*01 | chagas disease | NA | NA | NA | unclassified | |
| we previously reported protective haplotype hla-b*14:02-drb1*01:02 against chronic chagas disease in bolivia. | |||||||
| 23376085 | HLA (HLA) | chagas disease | NA | NA | NA | unclassified | |
| the mutant allele might play a primary role in the pathogenesis of chronic chagas disease in the associated hla region. | |||||||
| 23607422 | HLA-DR (HLA-DR) | chagas disease | NA | NA | NA | unclassified | |
| moreover, the expression of mhc-ii (hla-dr), cd80, cd86, caspase-3, granzyme b and intracellular il-10 and tgf-b by cd19+ b cells was higher in patients with chagas disease. | |||||||
| 25816096 | HLA-A*02 | chagas disease | NA | NA | NA | unclassified | |
| the tcca-2-specific cd8+ t cells were functionality evaluated by granzyme b and cytokine production in peripheral blood mononuclear cells (pbmc) from chagas disease patients stimulated with the identified hla-a*02:01 peptides. | |||||||
| 25978047 | HLA (HLA) | chagas disease | NA | NA | NA | unclassified | |
| killer cell immunoglobulin-like receptors and their hla ligands are related with the immunopathology of chagas disease. | |||||||
| 25978047 | HLA (HLA) | chagas disease | NA | NA | NA | unclassified | |
| the aim of this study was to investigate the influence of killer cell immunoglobulin-like receptor (kir) genes and their human leucocyte antigen (hla) ligands in the susceptibility of chronic chagas disease. | |||||||
| 26107442 | HLA-A*02 | chagas disease | NA | NA | NA | unclassified | |
| the immunogenic hla-a2-restricted t cell epitopes identified in this work may serve as potential components of an epitope-based t cell targeted vaccine for chagas disease. | |||||||
| 26265500 | HLA (HLA) | chagas disease | NA | benznidazole | NA | unclassified | |
| evaluation of cytokine profile and hla association in benznidazole related cutaneous reactions in patients with chagas disease. | |||||||
Copyright 2024